EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte Studie

Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam

Greg J Fox iD, Nguyen Viet Nhung, Nguyen Cam Binh, Nguyen Binh Hoa, Frances L Garden, Andrea Benedetti, Pham Ngoc Yen, Nguyen Kim Cuong, Emily L MacLean, H Manisha Yapa, David W Dowdy iD, Nguyen Huu Lan und 9 weitere

New England Journal of Medicine · 19.12.2024 · 391 (24) · 2304-2314

DOI: 10.1056/nejmoa2314325 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 19.12.2024. Verfasst von Greg J Fox und 20 weiteren Autor:innen. Beteiligte Einrichtung: From the Faculty of Medicine and Health (G.J.F., P.N.Y., E.L.M., H.M.Y., E.G.-R., P.D.C., B.J.M., N.T.A.), the Sydney Infectious Diseases Institute (…. Hauptthemen laut MEDLINE: Levofloxacin, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LevofloxacinMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultChildFemaleHumansMaleMiddle AgedYoung AdultAntitubercular AgentsDouble-Blind MethodRifampinVietnamAdministration, OralTuberculin TestPlacebosChild, PreschoolAgedAged, 80 and over

Substanzen

Antitubercular AgentsLevofloxacinRifampinPlacebos

Autor:innen und Institutionen

  • From the Faculty of Medicine and Health (G.J.F., P.N.Y., E.L.M., H.M.Y., E.G.-R., P.D.C., B.J.M., N.T.A.), the Sydney Infectious Diseases Institute (B.J.M.), and Sydney Medical School (H.M.Y.), University of Sydney, and…

ORCID-Profile: Greg J Fox, David W Dowdy, Dick Menzies, Guy B Marks

Förderung

  • National Health and Medical Research Council

Zitieren

APA

Fox, G. J., Nhung, N. V., Cam Binh, N., Hoa, N. B., Garden, F. L., Benedetti, A., Ngoc Yen, P., Cuong, N. K., MacLean, E. L., Yapa, H. M., Dowdy, D. W., Lan, N. H., Guevara-Rattray, E., Duc Cuong, P., Solomon, O., Behr, M. A., Marais, B. J., Graham, S. M., Menzies, D., …, & Marks, G. B. (2024). Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam. New England Journal of Medicine, 391(24), 2304-2314. https://doi.org/10.1056/nejmoa2314325

Vancouver

Fox GJ, Nhung NV, Cam Binh N, Hoa NB, Garden FL, Benedetti A, et al. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam. New England Journal of Medicine. 2024;391(24):2304-2314. doi:10.1056/nejmoa2314325

BibTeX
@article{Fox2024,
  author = {Fox, Greg J and Nhung, Nguyen Viet and Cam Binh, Nguyen and Hoa, Nguyen Binh and Garden, Frances L and Benedetti, Andrea and Ngoc Yen, Pham and Cuong, Nguyen Kim and MacLean, Emily L and Yapa, H Manisha and Dowdy, David W and Lan, Nguyen Huu and Guevara-Rattray, Elyse and Duc Cuong, Pham and Solomon, Ori and Behr, Marcel A and Marais, Ben J and Graham, Steven M and Menzies, Dick and Thu Anh, Nguyen and Marks, Guy B},
  title = {Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis in Vietnam},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {391},
  number = {24},
  pages = {2304--2314},
  doi = {10.1056/nejmoa2314325}
}
Kostenlos starten →